The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Most blockchains scale linearly. Add more users, and the system slows down. Zero Knowledge Proof (ZKP) takes a completely different route. Its design is built around recursive proofs, where one proof ...

Add Yahoo as a preferred source to see more of our stories on Google. BLOOMINGTON, IN — Controversy sometimes makes for strange bedfellows. An Indiana Daily Student newspaper box along Kirkwood Avenue ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...

International students can no longer work at the student paper at Purdue University after the administration made a host of changes to distance itself from the outlet. Over the summer, Purdue told the ...

Abstract: Distributed adaptive filtering has emerged as a critical methodology across diverse application domains, including wireless sensor networks, distributed signal processing, and intelligent ...

European private equity firm Exponent has raised more than €1 billion ($1.2 billion) for its latest flagship fund focused on mid-market investments. Exponent Private Equity Partners V has reached a ...

Rallybio has swerved away from its Recursion Pharmaceuticals pact, accepting $7.5 million upfront for its share of a preclinical program to extend its cash runway to mid-2027. Exscientia, now part of ...

Student journalists keep college students informed. Unfortunately, universities are distancing themselves from student newspapers, exacerbating the challenges young people face in finding trustworthy ...